Modern magnetic immunoassay: Biophysical and biochemical aspects
Abstract
In this review article an analysis of the biochemical and biophysical aspects of modern magnetic immunoassay (MIA) is conducted and additionally the problems and perspectives of its application in biology, biotechnology and medicine are defined. Magnetic immunoassay should be considered as an evolutionary extension of the classical immunoassay. MIA can have many variants of modifications, similar to the classic immunoenzymatic assay. The key distinctive element of the MIA is the use of magnetic particles (MPs), which are usually nanoparticles. MPs in the MIA can act as a marker for detection, or the solid phase at which the immunochemical reaction takes place. MIA possesses basic advantages over classical immunoassay methods: thanks to the unique magnetic properties of the MPs and the ability to manipulate it in the external magnetic field, it is possible to increase the informative value of the analysis (first of all, sensitivity and specificity), as well as the rigid requirements for “purity” of tested samples. For the purposes of immunoassay, magnetic particles of size from 10 to 200 nm are important, since such particles are in a superparamagnetic state, in the absence of strong magnetic fields; they are not agglomerated in a liquid medium. The size of the spherical particle determines the rate of sedimentation and mobility in the solution. The outer polymeric membrane serves as a matrix in which the surface functional groups are added, and also protects the core of the metal from the external environment. The outer shell may also consist of agarose, cellulose, porous glass, silicon dioxide etc. There are several strategies for the synthesis of nanoparticles: mechanical (dispersion), physical (gas phase deposition), wet chemical methods (chemical comprecipitation, thermal decomposition, methods of micro emulsion, hydrothermal reactions) and physico-chemical methods. Also used are magnesite nanoparticles of biogenic origin. Magnetic particles may function, and this is important for immunoassay. Surface functional groups include carboxylic, amino, epoxy, hydroxyl, tosyl, and N-hydroxysuccinate-activated groups. Magnetic spherical particles usually interact with surface molecules such as streptovidine, biotin, protein A, protein G, and immunoglobulin etc. Directions and prospects of the development of methods of magnetic immunoassay are determined, mainly, by the development of methods for detecting or influencing magnetic particles. In this case, the classical methods of detection are electrochemical methods, electrochemiluminescence, fluorescence. More modern ones include giant magnetoresistance, superconducting quantum interference devices, surface-enhanced Raman spectroscopy, biosensors based on nonlinear magnetization, magneto-PCR immunoassay. The current trend is to combine or integrate the application of various biochemical, physical, molecular and genetic, physico-chemical detection methods. In fact, all of these benefits undoubtedly open up broad prospects for the practical application of MIA in biology, biotechnology and medicine.References
Aseri, A., Kumar, G. S., Nayak, A., Trivedi, S. K., & Ahsan, J. (2015). Magnetic nanoparticles: Magnetic nano-technology using biomedical applications and future prospects. International Journal of Pharmaceutical Sciences Review and Research, 31(2), 119–131.
Choi, J. W., Oh, K. W., Thomas, J. H., Heineman, W. R., Halsall, H. B., Nevin, J. H., Helmicki, A. J., Henderson, H. T., & Ahn, C. H. (2001). An integrated microfluidic biochemical detection system for protein analysis with magnetic bead-based sampling capabilities. Lab on a Chip, 2(1), 27–30.
Galkin, А. Y. (2014a). Modern methods of serological diagnosis of infectious and non-infectious diseases: Enzyme immunoassay, lateral flow immunoassay, immumoblot. Journal of Health Sciences, 4(16), 179–188.
Gehring, A. G., Irwin, P. L., Reed, S. A., Tua, S., Andreotti, P. E., & Akhavan-Tafti, H. R. S. (2004). Enzyme-linked immunomagnetic chemiluminescent detection of Escherichia coli. Journal of Immunological Methods, 293, 97–106.
Gorobets, Y. I., Gorobets, S. V., & Gorobets, O. Y. (2013a). Biomineralization of intracellular biogenic magnetic nanoparticles and their expected functions. The Research Bulletin of the National Technical University of Ukraine “Kyiv Politechnic Institute”, 3, 28–33.
Gorobets, S. V., Gorobets, O. Y., & Demyanenko, I. V. (2013b). Self-organization of magnetite nanoparticles in providing Saccharamyces cerevisiaе yeasts with magnetic properties. Journal of Magnetism and Magnetic Materials, 337, 53–57.
Hermanson, G. (2008). Bioconjugate techniques (3rd ed.). Academic Press.
Kala, M., Bajaj, K., & Sinha, S. (1997). Magnetic bead enzyme-linked immunosorbent assay (ELISA) detects antigen-specific binding by phage-displayed scFv antibodies that are not detected with conventional ELISA. Analytical Biochemistry, 254, 263–266.
Kourilov, V., & Steinitz, M. (2002). Magnetic-bead enzyme-linked immunosorbent assay verifies adsorption of ligand and epitope accessibility. Analytical Biochemistry, 311(2), 166–170.
Mani, V., Chikkaveeraiah, B. V., & Rusling, J. F. (2011). Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring. Expert Opinion on Medical Diagnostics, 5(5), 381–391.
McConnell, S. J., Dinh, T., Le, M. H., & Spinella, D. G. (1999). Biopanning phage display libraries using magnetic beads vs. polystyrene plates. Biotechniques, 26(208–10), 214.
Mulvaney, S. P., Cole, C. L., Kniller, M. D., Malito, M., Tamanaha, C. R., Rife, J. C., Stanton, M. W., & Whitman, L. (2007). Rapid, femtomolar bioassays in complex matrices combining microfluidics and magnetoelectronics. Journal of Biosensors and Bioelectronics, 23(2), 191–200.
Nagasaki, Y., Kobayashi, H., Katsuyama, Y., Jomura, T., & Sakura, T. (2007). Enhanced immunoresponse of antibody/mixed-PEG co-immobilized surface construction of high-performance immunomagnetic ELISA system. Journal of Colloid and Interface Science, 309(2), 524–530.
Nikitin, P., Ksenevich, T., Nikitin, M., & Gorshkov, B. (2008a). Opto-magnetic assays based on magnetic nanoparticles and optical label-free biosensors. Proceedings of Ninth European Conference on Optical Chemical Sensors and Biosensors, EUROPT(R)ODE IX, Dublin, P. OA4.2.
Orlov, A. V. (2014). Razrabotka metodov immunoanaliza s ispol’zovaniem magnitnyih nanomarkerov [Development of immunoanalization methods using magnetic nanomarkers]. Moscow (in Russian).
Svobodova, Z., Krulisova, P., Cerna, M., Jankovicova, B., & Bilkova, Z. (2015). On-chip ELISA on magnetic particles: Isolation and detection of specific antibodies from serum. Nanocon 2015: 7th International Conference, Brno, Czech Republic, EU.
Tsai, H. Y., Hsu, C. F., Chiu, I. W., & Fuh, C. B. (2007). Detection of C-reactive protein based on immunoassay using antibody-conjugated magnetic nanoparticles. Analytical Chemistry, 79(21), 8416–8419.
Wacker, R., Ceyhan, B., Alhorn, P., Schueler, D., Lang, C., & Niemeyer, C. M. (2007). Magneto immuno-PCR: A novel immunoassay based on biogenic magnetosome nanoparticles. Biochemical and Biophysical Research Communications, 357(2), 391–396.
Wu, W., Wu, Z., Yu, T., Jiang, C., & Kim, W. S. (2015). Recent progress on magnetic iron oxide nanoparticles: Synthesis, surface functional strategies and biomedical applications. Science and Technology of Advanced Materials, 16(2), 023501.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.